📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial. (2017)

First Author: Chan D

Attributed to: EPICure@19 - the extremely preterm young adult funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1474-4422(17)30113-8

PubMed Identifier: 28600189

Publication URI: http://europepmc.org/abstract/MED/28600189

Type: Journal Article/Review

Volume: 16

Parent Publication: The Lancet. Neurology

Issue: 8

ISSN: 1474-4422